Literature DB >> 4793878

Pharmacokinetics of cephanone in healthy adult volunteers.

C Regamey, W M Kirby.   

Abstract

Five volunteers received intramuscular injections of 7 mg (approximately 500 mg) of cephanone, a new cephalosporin for parenteral use per kg. Peak serum concentrations averaged 36 mug/ml, about four times as high as with the same doses of cephalothin, twice as high as with cephaloridine, and slightly lower than with cefazolin. With a constant intravenous infusion of 100 mg/h, a steady-state serum concentration of 31 mug/ml was attained in four volunteers. The serum half-life was similar for the intramuscular and intravenous studies, 2.4 and 2.6 h, respectively. Over 90% of the dose administered was recovered in the urine. The factor mainly responsible for the higher and more sustained serum concentrations of cephanone was its low renal clearance of 47 ml per min per 1.73 m(2). Cephanone has a small apparent volume of distribution, probably related to its high serum protein binding of 88%.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4793878      PMCID: PMC444601          DOI: 10.1128/AAC.4.6.589

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Clinical studies of cefazolin in the surgical field.

Authors:  K Shibata; M Fujii
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

2.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

3.  Comparative blood levels of hetacillin, ampicillin and penicillin G.

Authors:  S B Tuano; L D Johnson; J L Brodie; W M Kirby
Journal:  N Engl J Med       Date:  1966-09-22       Impact factor: 91.245

4.  A rapid, modified ultrafiltration method for determining serum protein binding and its application to new penicillins.

Authors:  J V Bennett; W M Kirby
Journal:  J Lab Clin Med       Date:  1965-11

5.  Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients.

Authors:  W M Kirby; J B De Maine; W S Serrill
Journal:  Postgrad Med J       Date:  1971-02       Impact factor: 2.401

6.  Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration.

Authors:  S B Tuano; J L Brodie; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

7.  Cephaloridine therapy as related to renal function.

Authors:  S A Kabins; S Cohen
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

8.  Laboratory and clinical comparison of cephaloridine and cephalothin.

Authors:  E J Benner; J S Brodie; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

9.  Cephanone: in vitro antibacterial activity and pharmacology in normal human volunteers.

Authors:  B R Meyers; S Z Hirschman; P Nicholas
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

10.  Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Authors:  W E Wick; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

View more
  2 in total

1.  In vitro studies with cephanone.

Authors:  S Shadomy; C Kirchoff; G Wagner
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

2.  Binding of aminoglycosides to feces.

Authors:  G H Wagman; J V Bailey; M J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.